Source Bizjournals:
Oregon Health & Science University isn’t rushing to use a new a Multiple Sclerosis therapy that uses a person’s own stem cells.
Dr. Richard Burt, chief of the division of immunotherapy at Northwestern University’s Feinberg School of Medicine, on Friday spoke to a group of physicians at OHSU’s Multiple Sclerosis Center about use of hematopoietic stem cell transplant (HSCT). Read on.
